1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 5: 
Association of major procedural complications and embolectomy device
Type of ComplicationMERCI % (n/N) [events]Solitaire % (n/N) [events]P
SAH symptomatic7.3% (4/55) [4]1.1% (1/89) [1].070
SAH asymptomatic5.5% (3/55) [3]3.4% (3/89) [3].67
ICH PH1 symptomatic1.8% (1/55) [1]0.0% (0/89) [0].38
ICH PH2 symptomatic1.8% (1/55) [1]0.0% (0/89) [0].38
IVH symptomatic1.8% (1/55) [1]0.0% (0/89) [0].38
ICH asymptomatic27.3% (15/55) [15]27.0% (24/89) [25]1.00
Ischemic stroke symptomatic12.7% (7/55) [7]3.4% (3/89) [3].044
All symptomatic ICH10.9% (6/55) [6]1.1% (1/89) [1].013
Air emboli1.8% (1/55) [1]1.1% (1/89) [1]1.00
Emboli to same vascular territory5.5% (3/55) [3]4.5% (4/89) [4]1.00
Emboli to new vascular territory1.8% (1/55) [1]0.0% (0/89) [0].38
Device detachment0.0% (0/55) [0]0.0% (0/89) [0]1.00
Vessel dissection1.8% (1/55) [1]4.5% (4/89) [4].65
Vessel vasospasm on angiography16.4% (9/55) [10]22.5% (20/89) [20].40
Vessel vasospasm symptomatic0.0% (0/55) [0]0.0% (0/89) [0]1.00
Major access site issues3.6% (2/55) [2]7.9% (7/89) [8].48
Study device–related AE16.4% (9/55) [13]10.1% (9/89) [14].31
Ancillary device–related AE3.6% (2/55) [2]7.9% (7/89) [8].48
Technical difficulty with device7.3% (4/55) [4]10.1% (9/89) [12].77
  • Note:—IVH indicates intraventricular hemorrhage; ICH, intracerebral hemorrhage; AE, adverse event.